Substance dependence is a complex environmental and genetic disorder that results in serious health and socioeconomic consequences. Many studies have reported and implicated genes associated with various substance dependence outcomes, including addiction to nicotine and addiction to alcohol. Using data from several genome-wide case-control studies, we conducted a genome-wide association study of a composite substance dependence phenotype derived from six individual diagnoses: addiction to nicotine, alcohol, marijuana, cocaine, opiates, or other drugs as a whole. We identified a strong (odds ratio ‫؍‬ 1.77) and significant (P value ‫؍‬ 7E-8) association signal with the PBX/knotted 1 homeobox 2 (PKNOX2) gene on chromosome 11 in European-origin women with the composite phenotype. Our findings also indicate that the associations are not as significant when individual outcomes for addiction are considered, underscoring the importance of considering multiple addiction types.
comorbidity ͉ genetics of addiction ͉ genomewide association T here is strong evidence that vulnerability to substance dependence or addiction (drugs, alcohol, or smoking) is a complex trait with both genetic and environmental components (1) (2) (3) . Whether legal or illicit, substance abuse is one of the most sought-after phenomena in many populations because of its serious health and socioeconomic consequences. In 2008, the Centers for Disease Control and Prevention estimated that 443,000 deaths were caused by cigarette smoking and exposure to second-hand smoke (4) . In addition, alcohol misuse has been linked to attempted and successful suicide, particularly among adolescents (5) . Clearly, a better understanding of the genetics behind vulnerability to addictions could tremendously improve overall health and quality of life in general. A useful start in this direction is given by Kreek et al. (6) In the literature, candidate genes for addiction to alcohol, nicotine, and other substances individually have been identified. For example, GABRA2, CHRM2, and ADH4 are well studied for alcohol addiction and have been replicated in many samples (7-10), while several newer candidate genes, such as GABRG3, TAS2R16, SNCA, OPRK1, and PDYN, remain to be confirmed (11) . Many variants at the aldehyde dehydrogenase (ALDH) and alcohol dehydrogenase (ADH) loci have also been well-documented, especially in East-Asian populations (12) (13) (14) (15) . Several studies also report a gene cluster of nicotinic acetylcholine receptors (CHRNA5, CHRNA3, and CHRNB4) and Neurexin1 show allelic differences in heavy vs. light smokers (16) (17) (18) (19) . Li (20) reported 13 regions on chromosomes 3-7, 9-11, 17, 20, and 22 to be significantly associated with nicotine dependence in at least two independent samples, although a significant number of reported genomic regions did not reach the level of ''suggestive'' or ''significant'' linkage and failed to be replicated in other independent studies.
Although individually different substance dependence outcomes have been previously studied, substance dependence as a whole, combining addiction to nicotine, alcohol, marijuana, cocaine, opiates, and other drugs, has not been thoroughly investigated in association studies. We hypothesize that there is a common genetic predisposition for the composite substance dependence phenotype that may not be apparent when individual addiction conditions are considered. A review of this topic is given by Li and Burmeister (21) . The availability of the Gene Environment Association Studies Genes and Environment Initiative Study of Addiction: Genetics and Environment (SAGE) data provides an unprecedented opportunity to study the genetics of a composite trait: namely, addiction to at least two of the six substances under study (nicotine, alcohol, marijuana, cocaine, opiates, and other drugs).
In this report, we present a significant association at the genomewide level (␣ ϭ 0.05) of the PKNOX2 gene on chromosome 11 with substance dependence in European-origin women. PKNOX2 has been previously identified as one of the cis-regulated genes for alcohol addiction in mice (22) . However, to our knowledge, PKNOX2 has not been reported to be associated with any substance addiction outcomes in human populations. We have identified a cluster of markers in the region of the PKNOX2 gene that are strongly associated with a composite addiction at the genomewide level. We also investigate potential sex-specificity and racial differences in the association. Table 1 summarizes the top eight significant SNPs which cluster in PKNOX2 on chromosome 11 (11q24). None of the eight SNPs violates the Hardy-Weinberg equilibrium assumption (minimum P level ϭ 0.12). The most significant SNP (rs12284594; P ϭ 7.13E-08) is observed in white women with an odds ratio (OR) of 1.77; thus, those who have the risk allele (G) for rs12284594 are at significantly increased risk of being diagnosed with at least two of the six categories of substance dependence. This P value reaches the accepted genome-wide significance level (23) . In addition, there are seven other SNPs with P values less than 3.8E-06 in white women, and the corresponding ORs are similar in magnitude (1.63-1.72). We also examined haplotypes in this region, but they did not enhance the strength of the associations; hence, these results are not reported here. Similarly, when related individuals were included in the analysis, the strength of association was not enhanced, whether the analysis was performed using PedGenie (24), or whether the correlation among related individuals was ignored. Although we also observed that these eight SNPs confer increased risk in white men, black men, and black women, they fail to reach genome-wide significance. Hence, detailed results are not presented here for these groups.
Results
Additional analyses were performed to examine each substance dependence outcome separately for the top eight SNPs presented above. The corresponding P values for the eight SNPs for each substance dependence outcome are presented in Table  2 . Alcohol dependence shows the strongest association (P ϭ Author contributions: X.C., K.C., and H.Z. designed research; X.C., K.C., B.H.S., and H.Z. performed research; X.C., K.C., and H.Z. contributed new reagents/analytic tools; X.C., K.C., and H.Z. analyzed data; and X.C., K.C., B.H.S., and H.Z. wrote the paper.
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1.97E-06 with rs12284594); however, none of these P values attains the genomewide significance level of 0.05.
Discussion
We have found a genome-wide significant association of a composite substance dependence phenotype with a SNP in the PKNOX2 gene in white women. PKNOX2, PBX/knotted 1 homeobox 2, belongs to the three-amino acid loop extension (TALE) homeobox family. Homeodomain proteins are highly conserved transcription regulators. PKNOX2 was identified as a TALE homeodomain-encoding gene, located at 11q24 in humans by Imoto et al. (25) . They reported that the structure and subcellular localization of PKNOX2 indicate that this protein functions as a nuclear transcription factor. Several years later, PKNOX2 was identified as one of the cis-regulated genes for alcohol addiction in mice (22) . However, PKNOX2 has not been reported to be associated with any substance dependence phenotype in humans to date. The composite dichotomous substance dependence variable reflects cases with two or more addictions where the top three categories are alcohol, nicotine and cocaine (Fig. 1) . Among all subjects, 47% have been diagnosed with alcohol dependence in combination with other substance dependence outcomes. Our results, which show a strong association of this composite substance dependence variable with PKNOX2 gene in a human sample, support the experimental findings in mice by Mulligan et al. (22) . Thus our findings make an important contribution in reporting PKNOX2 as a candidate gene for substance dependence in humans, particularly for white women in the SAGE sample.
In addition, among our most significant SNPs, we do not observe those genes previously reported for alcoholism or nicotine. Rather we find a set of genes among the top SNPs. When each substance dependence outcome was individually analyzed for association with the eight most significant SNPs, we found no association that reached genomewide significance. This suggests that substance dependence or addiction as a whole has different risk genes compared to any single addiction outcome.
It may also mean that there is more power in detecting common genes acting upon co-morbid addiction outcomes as a whole. Different ethnic groups have vastly different underlying genetics for many complex diseases, and these differences may confound association results when they are pooled together as one in the analysis. Previously, racial differences in the prevalence of substance abuse have been reported (26) (27) (28) . More recently, Luo et al. (29) have reported that genetic differences between black smokers and white smokers influence the nature of their nicotine dependence; they found that black smokers become dependent at a lower threshold (number cigarettes per day) than white smokers. In the presence of subjects in different ethnic populations in the data, it is crucial to investigate and control for potential confounding by stratification and admixture due to disequilibrium between pairs of unlinked loci (30) . We investigated these two major ethnic groups separately in our analysis. In addition, we stratified our analysis by gender; based on the premise that gender may be a confounding factor for the The high-risk allele is in the parenthesis. substance dependence outcome, men may be socially more prone to environmental influences promoting substance use, and thus more vulnerable to addiction, compared to women (31).
Our results from the two ethnic groups do not corroborate each other, which underscores the underlying genetic differences in white and black samples. In fact, strong association signals are observed only in the white woman sample. With a heterogeneous population like SAGE, one must be cautious in analyzing and interpreting the results. The identification of PKNOX2 as a candidate gene for substance use disorders underscores two important issues: (a) this has not been possible in the past due to limited sample size, and (b) we have considered a composite trait of six substance dependence outcomes as a whole. The association becomes less significant if individual substance addictions are considered. Thus, this highlights the importance of studying highly comorbid disorders or those which might otherwise have a common pathway. However, our study is limited to the information in the available data, and we acknowledge the difficulty in operationalizing substance dependence; whether our operationalization of addiction to two or more substances, truly reflects the strength of the addiction phenotype is open to question. Indeed, it may simply reflect the extent of access to drugs. We also recognize that dependence on one substance shows different characteristics from dependence on another, and it is valuable and necessary to study them as individual entities. However, our call for more attention to comorbidity and the combinatorial study of these disorders should be viewed as a valuable complementary effort.
Methods
Study of Addiction: Genetics and Environment (SAGE) Data. We obtained the genome-wide single nucleotide polymorphisms (SNP) data from the database of Genotype and Phenotype (dbGaP). The data were from the Study of Addiction: Genetics and Environment (SAGE), which originally included 4,121 subjects for whom the addiction to the six categories of substances and genome-wide SNP data (ILLUMINA Human 1M platform) were available. SAGE is a case-controlled study of mostly unrelated individuals aimed at identifying genetic associations for addiction. Cases and controls were selected from three large, complementary cohorts: Collaborative Study on the Genetics of Alcoholism (COGA), Family Study of Cocaine Dependence (FSCD), and Collaborative Genetic Study of Nicotine Dependence (COGEND). These three studies have been previously described (8, 29, 32, 33) . Lifetime dependence on nicotine, alcohol, marijuana, cocaine, opiates, or other dependence on other drugs was diagnosed in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). As stated above, we studied a composite addiction phenotype according to whether a subject was addicted to substances in at least two of the aforementioned categories.
Subject Characteristics and Study Design. In our study, we filtered SNPs by setting thresholds for minor allele frequency (MAF) and call rate (i.e., MAF Ͼ5% and call rate Ͼ90%). The initial filtering was done to reduce the level of noise in genotypes and increase the efficiency of analysis. In addition, we excluded 60 duplicate genotype samples and removed nine subjects with ethnic backgrounds other than African origin (black) or European origin (white). Table 3 lists the descriptive statistics of the sample included in our study. Almost all subjects were either black (30.3%) or white (69.4%). In our final analysis, a total of 3,627 unrelated subjects with 830,696 autosomal SNPs were included. The final subset considered in the analysis consisted of 45.9% men and 54.1% women with mean ages of 39.4 and 38.6 years old, respectively. Because substance dependence is a complex disease with both genetic and environmental components, we analyzed the male and female subsets separately. In addition, we performed separate analysis for blacks and whites in light of the possibility that underlying genetic variants may be different in different ethnic groups. Thus our study included four subsamples: 1,393 white women, 1,131 white men, 568 black women, and 535 black men. For each subset, the proportions of subjects diagnosed with lifetime dependence on substances in each of the six categories-nicotine, alcohol, marijuana, cocaine, opiates or other drugs-are summarized in Table 3 .
Statistical Analysis. Because of the presence of different ethnic populations in our data, it was crucial for us to investigate and control for potential confounding by stratification and admixture due to disequilibrium between pairs of unlinked loci (30) . To avoid potential population stratification, we first stratified our analysis by race and sex. Then we performed formal population stratification analysis for each subset using PLINK software (version 1.04) (34) . The results confirmed that each subset comes from a homogenous population; thus no further adjustment was needed to control for potential confounding by stratification and admixture. Overall a total of 1,513 subjects were defined as having two or more substance addictions according to DSM-IV. Of these, there were 316, 585, 237, and 357 subjects in the black male, white male, black female, and white female subsets, respectively. The distribution of subjects diagnosed with each substance dependence is presented in Table 3 . The top three most widely used substances among the six were alcohol, nicotine and cocaine, in that order (Fig. 1) .
We used allelic 2 tests with one degree of freedom in our analysis, stratified by race and sex. Haploview (version 4.0) (35) was used to analyze the linkage disequilbrium in the PKNOX2 gene region and the association between the haplotypes and the composite phenotype. We performed additional analyses by examining and comparing the results of including and excluding 214 related subjects in the data. For mixtures of unrelated and related subjects, we used PedGenie (24) to perform association analyses. PedGenie first performs the allelic 2 tests treating all individuals independently then takes the pedigree information into account to assess statistical significance through permutation analysis.
Determination of Significance Threshold for GWAS.
Using genotypes from the Wellcome Trust Case-Control Consortium, Dudbridge and Gusnanto (23) studied the genomewide significance threshold for the U.K. Caucasian population. They subsampled the genotypes at different densities and estimated the threshold for 5% family-wise error using permutations. They then extrapolated to infinity density and estimated that the genomewide significance threshold for this population is 7.2E-8. We used this genome-wide significance threshold (7.2E-8) for the Caucasian population (white men and white women) in our analysis.
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